Jenphar SPD hosted an Award show titled “Onco Icons Award” which was first of its kind on the occasion of International Women’s Day to inspire the Female Oncologists of Bangladesh on 8th…

Jenphar was recognized as a “Green Champion” for their collaborative efforts with Mutual Trust Bank PLC in implementing Climate Mitigation Technologies at Jenphar Plant.The magnanimous event, ‘Fostering Climate Finance Partnership in Bangladesh’,…

Jenphar Bangladesh Limited has achieved a remarkable milestone by registering its groundbreaking oncology product Olaparib INN Tablet (Juparib 100 mg & 150 mg) in Sri Lanka.With its recent registration approval, Olaparib INN…

Jenphar Bangladesh Limited, has stepped up in the oncology market with its new product HER-2N 200 tablet, preparation of Ribociclib Succinate 200 mg Tablet.HER-2N is a CDK4/6 inhibitor that is indicated for…

Jenphar Bangladesh Limited is pleased to announce the successful launch of new oncology product Pazopanib Hydrochloride 400 mg tablet as the brand name of Zotrix 400 tablet.Pazopanib Hydrochloride is an oral, potent,…

Jenphar manufacturing site, a state of art facility achieves a triumph by registering their company in Syria which has opened a new door for export.The delegates of Syrian Ministry of Health (MOH)…